三维超声与磁追踪对腹主动脉瘤的全容积评估
本研究纳入20例腹主动脉瘤患者,比较标准三维超声与两种基于磁追踪的扩展视野三维超声协议(XFoV-2-D和XFoV-3-D)实现全容积评估的能力,并以计算机断层血管造影为参照。排除4例图像质量不佳者后,16例可分析患者中标准协议全容积成功率50%,XFoV-2-D为69%,XFoV-3-D为81%。作者认为两种新协议可行,并应启动进一步研究评估全容积在腹主动脉瘤监测中的附加价值。
要点
- 标准三维超声因视野受限仅能在60%患者中完成全腹主动脉瘤采集。
- XFoV-3-D协议在16例可分析患者中全容积成功率达81%,高于标准协议的50%。
- XFoV-2-D协议全容积成功率为69%,介于标准协议与XFoV-3-D之间。
诊断标准与关键数值
- 全腹主动脉瘤容积获取成功率:标准三维超声协议8/16例(50%),XFoV-2-D协议11/16例(69%),XFoV-3-D协议13/16例(81%)。
局限性
- 当前三维超声技术的主要局限是视野有限,仅能在60%患者中完成全腹主动脉瘤采集。
- 4例患者因图像质量低被排除进一步分析。
- 作者指出应启动进一步研究评估全容积在腹主动脉瘤监测中的附加价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Volume assessment of abdominal aortic aneurysms (AAAs) using 3-D ultrasound (US) is an innovative technique reporting good agreement with computed tomography angiography. One major limitation of the current 3-D US technique is a limited field of view, allowing full AAA acquisition in only 60% of patients. This study presents two new US acquisition protocols using magnetic field tracking, providing an "extended field of view" (XFoV-2-D and XFoV-3-D) with the aim of including both the aortic bifurcation and neck for full-volume assessment, and compares these methods with the current standard 3-D US protocol and with computed tomography angiography. A total of 20 AAA patients were included and underwent the current standard 3-D US protocol and the two novel 3-D US "extended field of view" protocols. Four patients were excluded from further analysis because of low image quality, leaving 16 patients eligible for analysis. Full AAA volume was achieved in 8 patients (50%) using the standard 3-D US protocol, in 11 patients (69%) with the XFoV-2-D protocol and in 13 patients (81%) with the XFoV-3-D protocol. In conclusion, this article describes two new and feasible US protocols applicable for full-AAA-volume estimation in most patients and should initiate further research into the added value of full volume in AAA surveillance.
引用
- Zielinski AH, Bredahl KK, Ghulam Q, et al. Full-Volume Assessment of Abdominal Aortic Aneurysms by 3-D Ultrasound and Magnetic Tracking. Ultrasound Med Biol. 2020. PMID: 32988672. doi:10.1016/j.ultrasmedbio.2020.09.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。